Clinical trials in cancer treatment: what they are and how they work

A clinical trial is a carefully planned research study that tests a new medicine, a new combination, a new way of giving treatment or a new test in people. It is the only reliable way to find out whether something new is safer or works better than the care already in use. Every standard cancer treatment used today was once tested in trials like these. Trials are not only for people who have run out of choices. Some compare two accepted treatments, some study ways to ease side effects, and some look at quality of life. Joining is always voluntary, and a trial may or may not help the person who takes part.

Trials move through stages called phases. A phase one trial is small and mainly asks whether a new treatment is safe and what amount can be given. A phase two trial gives it to more people to see whether it acts against a particular cancer. A phase three trial compares it with the current standard treatment in a large group, often by randomisation, which means a computer decides which treatment each person receives. A phase four study follows a medicine after approval to watch for rarer or longer-term effects. Each phase answers a different question, so the purpose of a trial shapes what taking part involves. Always ask which phase you are being offered.

Trials are run by teams of doctors, nurses, pharmacists and research coordinators at hospitals and research centres. They may be funded by a drug company, a government body, a university or a charity. In India, a trial of a new medicine needs approval from the national drug regulator, review by an ethics committee, and registration on the Clinical Trials Registry – India, known as CTRI, before anyone is enrolled. Ethics committees can pause or stop a trial if participants are put at unfair risk during the study. Your treating oncologist is the right person to tell you whether any trial is relevant to your situation, and the decision to join always stays with you.

A trial is research, not a promise

It exists to answer a question, which may or may not help you.

Phases ask different questions

Early phases focus on safety; later phases compare treatments.

Oversight comes before enrolment

Approval, ethics review and CTRI registration come first.

It cannot tell you whether a suitable trial exists for your cancer, or whether joining one would be right for you. That depends on your diagnosis, your health and what trials are open.

It also cannot predict whether a trial treatment would help you. Only your oncologist can weigh your options.

Why trials matter in India

Many treatments are first tested in other countries, yet people in India may respond differently because of genetics, diet, other illnesses and the cancers that are common here. Trials run in Indian hospitals help doctors know how treatments work for Indian families. Few patients are ever told about them, which is why this explanation matters.

Types of trial

Treatment trials test new medicines or combinations. Other trials test screening methods, ways of preventing cancer, ways of easing side effects such as sickness or pain, or support for emotional wellbeing and nutrition. Some trials only collect information or samples and do not change your treatment at all. Ask which type is being described.

Randomisation explained

In a randomised trial, a computer allocates each person to a group by chance. This keeps the groups similar, so any difference in results comes from the treatment rather than from who was chosen. Neither you nor your doctor picks the group. That can feel uncomfortable, and it is fair to ask how each group is treated.

Placebos, honestly

A placebo is a dummy treatment that looks like the real one. In cancer trials it is rarely used on its own when an effective treatment exists. More often, everyone receives standard treatment and one group also receives the new medicine while the other receives a dummy. The consent form must say whether a placebo is used.

Standard care versus trial care

Standard care is the treatment with the strongest current evidence for your situation. Trial treatment is being tested because doctors do not yet know whether it is better. It may turn out better, similar or worse. Your oncologist should explain both paths side by side before you decide anything at all.

Who pays for what

Usually the sponsor pays for the trial medicine and tests needed only for the research. Routine care that you would have needed anyway may still be your cost, and travel may or may not be reimbursed. This varies from trial to trial, so ask for the arrangements in writing before you agree.

Your right to say no

Saying no to a trial will not affect the care you receive. Your oncologist will continue to treat you with the best available standard treatment. You can also join a trial and later withdraw at any time, without giving a reason, and return to standard care. This right is part of every properly run trial.

How ethics committees protect you

An ethics committee includes doctors and people from outside medicine, such as legal experts and lay members. It reviews the study plan, the consent form and any payments before a trial starts, and it can pause or stop a trial if participants are put at unfair risk. You may contact it with concerns.

What CTRI is

The Clinical Trials Registry – India is a public online register. Trials involving people in India are expected to be registered there before anyone is enrolled. Each entry describes the aim, the centres taking part and who to contact. It is a useful way to check that a trial you hear about is on record.

Why eligibility is strict

Each trial has rules about who can join, based on cancer type, earlier treatment, blood tests and general health. These rules protect participants and make results reliable. Many people do not qualify for a particular trial, and that says nothing about their care or their chances. Your team can explain the reasons.

What taking part involves

Trials often need extra visits, blood tests, scans or questionnaires, and sometimes careful diaries of symptoms. For families travelling from a district town, this can mean more time, travel and lost work. Ask for the full schedule before deciding, so you can judge honestly whether it is manageable for your household.

Bringing family into the decision

Many Indian families make treatment decisions together. It is reasonable to take a relative to trial discussions, ask for information in your own language, and take the forms home to read. A good research team will welcome questions and never rush a family into signing anything before they are ready.

What to do next

Ask your treating oncologist whether a trial is relevant to you, request written information in a language you read comfortably, check the trial on CTRI, and take time to discuss it with your family before deciding.